Published in Am J Hum Genet on January 01, 1995
The Princeton Protein Orthology Database (P-POD): a comparative genomics analysis tool for biologists. PLoS One (2007) 1.83
Subunit interactions and composition of the fructose 6-phosphate catalytic site and the fructose 2,6-bisphosphate allosteric site of mammalian phosphofructokinase. J Biol Chem (2009) 0.94
Functional linkage of adenine nucleotide binding sites in mammalian muscle 6-phosphofructokinase. J Biol Chem (2012) 0.86
A novel role of the yeast CaaX protease Ste24 in chitin synthesis. Mol Biol Cell (2010) 0.82
Identification of C-terminal motifs responsible for transmission of inhibition by ATP of mammalian phosphofructokinase, and their contribution to other allosteric effects. Biochem J (2004) 0.81
Divergence of eukaryotic secretory components: the Candida albicans homolog of the Saccharomyces cerevisiae ++Sec20 protein is N terminally truncated, and its levels determine antifungal drug resistance and growth. J Bacteriol (2001) 0.80
Nonsense mutation in the phosphofructokinase muscle subunit gene associated with retention of intron 10 in one of the isolated transcripts in Ashkenazi Jewish patients with Tarui disease. Proc Natl Acad Sci U S A (1995) 0.78
Glycogenosis type VII (Tarui disease) in a Swedish family: two novel mutations in muscle phosphofructokinase gene (PFK-M) resulting in intron retentions. Am J Hum Genet (1996) 0.78
The sarcomeric M-region: a molecular command center for diverse cellular processes. Biomed Res Int (2015) 0.76
Unique Exercise Lactate Profile in Muscle Phosphofructokinase Deficiency (Tarui Disease); Difference Compared with McArdle Disease. Front Neurol (2016) 0.75
Crystallization and preliminary crystallographic analysis of human muscle phosphofructokinase, the main regulator of glycolysis. Acta Crystallogr F Struct Biol Commun (2014) 0.75
Glycolytic functions are conserved in the genome of the wine yeast Hanseniaspora uvarum and pyruvate kinase limits its capacity for alcoholic fermentation. Appl Environ Microbiol (2017) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Yeast/E. coli shuttle vectors with multiple unique restriction sites. Yeast (1986) 17.88
Detection and localization of single base changes by denaturing gradient gel electrophoresis. Methods Enzymol (1987) 10.90
Nearly all single base substitutions in DNA fragments joined to a GC-clamp can be detected by denaturing gradient gel electrophoresis. Nucleic Acids Res (1985) 6.52
Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat (1992) 4.48
Reduction of background problems in nonradioactive northern and Southern blot analyses enables higher sensitivity than 32P-based hybridizations. Anal Biochem (1993) 2.93
Phosphofructokinase: structure and control. Philos Trans R Soc Lond B Biol Sci (1981) 2.01
PHOSPHOFRUCTOKINASE DEFICIENCY IN SKELETAL MUSCLE. A NEW TYPE OF GLYCOGENOSIS. Biochem Biophys Res Commun (1965) 1.79
Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B. Nature (1990) 1.68
Cloning and expression of a human muscle phosphofructokinase cDNA. Gene (1989) 1.66
Muscle phosphofructokinase deficiency. Arch Neurol (1967) 1.54
Evolution of phosphofructokinase--gene duplication and creation of new effector sites. Nature (1984) 1.52
A review of animal phosphofructokinase isozymes with an emphasis on their physiological role. Mol Cell Biochem (1983) 1.33
Regional assignment of human liver-type 6-phosphofructokinase to chromosome 21q22.3 by using somatic cell hybrids and a monoclonal anti-L antibody. Hum Genet (1986) 1.26
Allosteric regulatory properties of muscle phosphofructokinase. Mol Cell Biochem (1983) 1.19
Assignment of the human gene for muscle-type phosphofructokinase (PFKM) to chromosome 1 (region cen leads to q32) using somatic cell hybrids and monoclonal anti-M antibody. Somatic Cell Genet (1982) 1.15
Isozymes of human phosphofructokinase in blood cells and cultured cell lines: molecular and genetic evidence for a trigenic system. Blood (1981) 1.12
Muscle phosphofructokinase deficiency: abnormal polysaccharide in a case of late-onset myopathy. Neurology (1981) 1.08
Studies on the function of yeast phosphofructokinase subunits by in vitro mutagenesis. J Biol Chem (1994) 1.06
Genetic defect in muscle phosphofructokinase deficiency. Abnormal splicing of the muscle phosphofructokinase gene due to a point mutation at the 5'-splice site. J Biol Chem (1990) 1.05
Influence of allosteric ligands on the activity and aggregation of rabbit muscle phosphofructokinase. Biochemistry (1973) 1.04
Rabbit muscle phosphofructokinase: studies on the polymerization. The behavior of the enzyme at pH 8, pH 6, and intermediate pH values. J Biol Chem (1972) 1.01
A 5' splice junction mutation leading to exon deletion in an Ashkenazic Jewish family with phosphofructokinase deficiency (Tarui disease). J Biol Chem (1993) 1.00
Structure of the entire human muscle phosphofructokinase-encoding gene: a two-promoter system. Gene (1991) 0.98
Nature of the subunits of the 6-phosphofructo-1-kinase isoenzymes from rat tissues. Biochem J (1987) 0.97
Identification of three novel mutations in non-Ashkenazi Italian patients with muscle phosphofructokinase deficiency. Am J Hum Genet (1994) 0.97
Common mutations in the phosphofructokinase-M gene in Ashkenazi Jewish patients with glycogenesis VII--and their population frequency. Am J Hum Genet (1994) 0.97
Phosphofructokinase in human blood cells. Blood (1979) 0.96
Cloning of human muscle phosphofructokinase cDNA. FEBS Lett (1987) 0.95
Alternative splicing of the transcript encoding the human muscle isoenzyme of phosphofructokinase. J Biol Chem (1990) 0.94
Tissue specificity in expression and alternative RNA splicing of human phosphofructokinase-M and -L genes. Biochem Biophys Res Commun (1990) 0.92
Transcriptional control of yeast phosphofructokinase gene expression. FEBS Lett (1991) 0.92
Transaldolase mutants in the yeast Kluyveromyces lactis provide evidence that glucose can be metabolized through the pentose phosphate pathway. Mol Microbiol (1993) 0.91
Evidence for alternative RNA splicing and possible alternative promoters in the human muscle phosphofructokinase gene at the 5' untranslated region. Biochem Biophys Res Commun (1990) 0.91
Regional assignment of the human gene for platelet-type phosphofructokinase (PFKP) to chromosome 10p: novel use of polyspecific rodent antisera to localize human enzyme genes. Hum Genet (1983) 0.91
Human 6-phosphofructo-1-kinase gene has an additional intron upstream of start codon. Gene (1989) 0.85
Hints for direct sequencing of PCR-generated single-stranded DNA. Biotechniques (1994) 0.85
Designing an allosterically locked phosphofructokinase. Biochemistry (1991) 0.84
Characterization of the enzymatic defect in late-onset muscle phosphofructokinase deficiency. New subtype of glycogen storage disease type VII. J Clin Invest (1987) 0.82
Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counseling. Hum Genet (1993) 0.82
Late-onset muscle phosphofructokinase deficiency. Neurology (1988) 0.78
Late-onset muscular weakness in phosphofructokinase deficiency due to exon 5/intron 5 junction point mutation: a unique disorder or the natural course of this glycolytic disorder? Neurology (1994) 0.78
Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med (1999) 8.01
A second set of loxP marker cassettes for Cre-mediated multiple gene knockouts in budding yeast. Nucleic Acids Res (2002) 5.38
Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet (2000) 4.37
Salicylic acid potentiates an agonist-dependent gain control that amplifies pathogen signals in the activation of defense mechanisms. Plant Cell (1997) 4.08
Effects of environmental tobacco smoke on urinary cotinine excretion in nonsmokers. Evidence for passive smoking. N Engl J Med (1984) 3.98
Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science (1995) 3.15
Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphoinositide 3-kinase. Nat Genet (1999) 2.81
Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis. Arthritis Rheum (2000) 2.72
Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut (2003) 2.71
Effects of size and shape (aspect ratio) on the hemodynamics of saccular aneurysms: a possible index for surgical treatment of intracranial aneurysms. Neurosurgery (1999) 2.43
Overproduction of glycolytic enzymes in yeast. Yeast (1989) 2.38
Load-bearing mode of the knee joint: physical behavior of the knee joint with or without menisci. Clin Orthop Relat Res (1980) 2.33
Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology (2006) 2.31
Self-reports versus sleep laboratory findings in 122 drug-free subjects with complaints of chronic insomnia. Am J Psychiatry (1976) 2.30
FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity. J Antibiot (Tokyo) (1994) 2.28
Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II. J Biol Chem (1998) 2.24
SOCS3 is essential in the regulation of fetal liver erythropoiesis. Cell (1999) 2.19
Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nat Genet (1992) 2.18
Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci U S A (2000) 2.13
Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study. Clin Exp Immunol (1985) 2.12
A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology (2011) 2.09
Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity. J Exp Med (1998) 2.07
Morphological changes after steroid therapy in autoimmune pancreatitis. Scand J Gastroenterol (2004) 2.06
IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology (2005) 2.06
Organic solvent tolerance and antibiotic resistance increased by overexpression of marA in Escherichia coli. Appl Environ Microbiol (1997) 1.98
Interferon gamma regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells. J Exp Med (1993) 1.95
Molecular cloning of the protocatechuate 4,5-dioxygenase genes of Pseudomonas paucimobilis. J Bacteriol (1990) 1.95
Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome. Am J Respir Crit Care Med (2000) 1.94
Rapid diagnosis of adenoviral conjunctivitis by PCR and restriction fragment length polymorphism analysis. J Clin Microbiol (1996) 1.94
Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice. Am J Respir Crit Care Med (2001) 1.94
Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation (2001) 1.89
Molecular composition of Clostridium botulinum type A progenitor toxins. Infect Immun (1996) 1.82
Enzymatic conversion of norsolorinic acid to averufin in aflatoxin biosynthesis. Appl Environ Microbiol (1991) 1.78
Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease. Am J Med Genet (1998) 1.75
Direct access to serum macromolecules by intraerythrocytic malaria parasites. Nature (1991) 1.72
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) (2003) 1.71
The distal region and receptor tyrosines of the Epo receptor are non-essential for in vivo erythropoiesis. EMBO J (2001) 1.67
Isolation and characterization of Aspergillus parasiticus mutants with impaired aflatoxin production by a novel tip culture method. Appl Environ Microbiol (1988) 1.64
Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease. Brain (1996) 1.64
Middle cerebral artery variations: duplicated and accessory arteries. AJNR Am J Neuroradiol (1998) 1.54
KRIT1 is mutated in hyperkeratotic cutaneous capillary-venous malformation associated with cerebral capillary malformation. Hum Mol Genet (2000) 1.53
A close correlation between improvement of organic solvent tolerance levels and alteration of resistance toward low levels of multiple antibiotics in Escherichia coli. Biosci Biotechnol Biochem (1995) 1.51
Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J Exp Med (1997) 1.51
Polymorphisms in alcohol metabolizing enzyme genes and alcoholic cirrhosis in Japanese patients: a multivariate analysis. Hepatology (1995) 1.49
The cholinergic rapid eye movement sleep induction test with RS-86. State or trait marker of depression? Arch Gen Psychiatry (1989) 1.49
Action of FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum no. 968, on Ha-ras transformed NIH3T3 cells. Biosci Biotechnol Biochem (1994) 1.49
Intussusception in adults. Mt Sinai J Med (2000) 1.47
Electron microscopy of equine infectious anemia virus. J Virol (1969) 1.46
Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase. Proc Natl Acad Sci U S A (1999) 1.46
Traumatic carotid cavernous sinus fistula: serial angiographic studies from the day of trauma. AJNR Am J Neuroradiol (1998) 1.45
Isolation and sequencing of a genomic clone for mouse brain specific small RNA. J Neurochem (1986) 1.44
Gallium alloy restorations in primary teeth: a 12-month study. J Am Dent Assoc (1996) 1.42
The World Health Organisation. Interview with the director general. Interview by Fiona Godlee. BMJ (1995) 1.41
Absence of measles viral genomic sequence in intestinal tissues from Crohn's disease by nested polymerase chain reaction. Gut (1996) 1.41
Dermatomyositis with splenic and renal infarctions during corticosteroid therapy. Intern Med (2000) 1.39
Monitoring of neuromuscular block after administration of vecuronium in patients with diabetes mellitus. Br J Anaesth (2003) 1.39
PULMONARY INFARCTION AND EMBOLISM. Ann Surg (1929) 1.37
Activation of Src family kinase yes induced by Shiga toxin binding to globotriaosyl ceramide (Gb3/CD77) in low density, detergent-insoluble microdomains. J Biol Chem (1999) 1.34
Importance of angina for development of collateral circulation. Br Heart J (1987) 1.32
Age-related change in pituitary threshold for TSH release during thyroxine replacement therapy for cretinism. J Clin Endocrinol Metab (1977) 1.30
Importance of collateral circulation for prevention of left ventricular aneurysm formation in acute myocardial infarction. Circulation (1989) 1.29
Surprises of genetic engineering: a possible model of polyglucosan body disease. Neurology (2001) 1.29
Endovascular treatment of traumatic aneurysms of the superficial temporal artery. J Trauma (1997) 1.28
Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells. Immunity (1998) 1.26
Involvement of heterotrimeric GTP-binding protein and rho protein, but not protein kinase C, in agonist-induced Ca2+ sensitization of skinned muscle of guinea pig vas deferens. J Pharmacol Exp Ther (1995) 1.26
Distinct roles for signals relayed through the common cytokine receptor gamma chain and interleukin 7 receptor alpha chain in natural T cell development. J Exp Med (1997) 1.24
Heteroplasmic point mutations of mitochondrial DNA affecting subunit I of cytochrome c oxidase in two patients with acquired idiopathic sideroblastic anemia. Blood (1997) 1.24
A motif in human histidyl-tRNA synthetase which is shared among several aminoacyl-tRNA synthetases is a coiled-coil that is essential for enzymatic activity and contains the major autoantigenic epitope. J Biol Chem (1994) 1.22
The correlation between tremor characteristics and the predicted volume of effective lesions in stereotaxic nucleus ventralis intermedius thalamotomy. Brain (1983) 1.22
Nonsense and missense mutations of the muscle chloride channel gene in patients with myotonia congenita. Hum Mol Genet (1994) 1.22
Oxidative Bioconversion of Cholesterol by Pseudomonas sp. Strain ST-200 in a Water-Organic Solvent Two-Phase System. Appl Environ Microbiol (1994) 1.22
High incidence of persistent primitive arteries in moyamoya and quasi-moyamoya diseases. Neurol Med Chir (Tokyo) (1999) 1.21
Do-not-resuscitate orders at a teaching hospital in Japan. N Engl J Med (1995) 1.21
Enzyme reactions and genes in aflatoxin biosynthesis. Appl Microbiol Biotechnol (2004) 1.20
Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system. Dement Geriatr Cogn Disord (2002) 1.20
Different signals control the activation of glycolysis in the yeast Saccharomyces cerevisiae. Yeast (1993) 1.19
Congenital deficiency of nitric oxide synthase 2 protects against endotoxin-induced myocardial dysfunction in mice. Circulation (2000) 1.19
Effect of diltiazem on electrical and mechanical activity of isolated cardiac ventricular muscle of guinea pig. Jpn J Pharmacol (1975) 1.19
Role of CD4(+) CD25(+) regulatory T cells in T helper 2 cell-mediated allergic inflammation in the airways. Am J Respir Crit Care Med (2001) 1.19
Stereochemistry during aflatoxin biosynthesis: conversion of norsolorinic acid to averufin. Appl Environ Microbiol (1993) 1.18
Stat5a regulates T helper cell differentiation by several distinct mechanisms. Blood (2001) 1.18
A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J Leukoc Biol (1999) 1.18
Interleukin 7 receptor control of T cell receptor gamma gene rearrangement: role of receptor-associated chains and locus accessibility. J Exp Med (1998) 1.18
Electrophysiological analysis of the vestibulospinal reflex pathway of rabbit. I. Classification of tract cells. Exp Brain Res (1973) 1.18
A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli. Clin Exp Immunol (1998) 1.17
Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation. Transplantation (1997) 1.17
Autoantibodies to thyroid peroxidase in patients with chronic thyroiditis: effect of antibody binding on enzyme activities. Clin Exp Immunol (1986) 1.17
Encysted peritoneal hydatidosis in a child -- the effectiveness of pre-operative therapy with a combination of praziquantel and albendazole. Ann Trop Med Parasitol (2005) 1.16
Prosthetic joint infection with Mycoplasma hominis. J Infect Dis (1986) 1.16
Physiologically controlled selective thalamotomy for the treatment of abnormal movement by Leksell's open system. Acta Neurochir (Wien) (1977) 1.16
Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease. Hum Pathol (1990) 1.16
Specificity of the high affinity interaction of protein kinase C with a physiological substrate, myristoylated alanine-rich protein kinase C substrate. J Biol Chem (1994) 1.14
Mouse liver metallothioneins. Purification, molecular weight, amino acid composition, and metal content. J Biol Chem (1978) 1.14
Drinking deep-sea water restores mineral imbalance in atopic eczema/dermatitis syndrome. Eur J Clin Nutr (2005) 1.14
Simple method for detection of Clostridium botulinum type A to F neurotoxin genes by ploymerase chain reaction. Microbiol Immunol (1996) 1.14
A novel heme protein that acts as a carbon monoxide-dependent transcriptional activator in Rhodospirillum rubrum. Biochem Biophys Res Commun (1996) 1.13
Increased levels of surfactant protein A and D in bronchoalveolar lavage fluids in patients with bronchial asthma. Eur Respir J (2000) 1.13
Molecular characterization of a novel human natural killer cell receptor homologous to mouse 2B4. Tissue Antigens (1999) 1.13